Echinococcus multilocularis metacestodes modulate cellular cytokine and chemokine release by peripheral blood mononuclear cells in alveolar echinococcosis patients

Clinical and Experimental Immunology

Volumn 145, Issue 2, 2006, Pages 243-251

  Hubner M P ^a   Manfras, B J ^b,c   Margos, M C ^a   Eiffler, D ^a   Hoffmann, W H ^a   Schulz Key, H ^a   Kern, P ^b   Soboslay, P T ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c MVZ Endokrinologikum Ulm   (Germany)

Author keywords

Alveolar echinococcosis; Cytokine and chemokine responses; Echinococcus multilocularis

Indexed keywords

CD28 ANTIGEN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MACROPHAGE DERIVED CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PARASITE ANTIGEN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL ACTIVATION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ECHINOCOCCOSIS; ECHINOCOCCUS MULTILOCULARIS; FEMALE; HOST; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; LUNG ALVEOLUS; MACROPHAGE; MALE; MOLECULE; PARASITE; PARASITE CULTIVATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SUPERNATANT; TH1 CELL; TH2 CELL; THYMUS; TISSUE INJURY;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIGENS, CD28; ANTIGENS, HELMINTH; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHEMOKINES; CHEMOKINES, CC; CYTOKINES; ECHINOCOCCOSIS, PULMONARY; ECHINOCOCCUS MULTILOCULARIS; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PARASITOLOGY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745946674     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03142.x     Document Type: Article

References (39)

1. Gottstein B, Hemphill A. Immunopathology of echinococcosis. Chem Immunol 1997; 66:177-208.
2. Gottstein B, Saucy F, Deplazes P et al. Is high prevalence of Echinococcus multilocularis in wild and domestic animals associated with disease incidence in humans? Emerg Infect Dis 2001; 7:408-12.
3. Bresson-Hadni S, Laplante JJ, Lenys D et al. Seroepidemiologic screening of Echinococcus multilocularis infection in a European area endemic for alveolar echinococcosis. Am J Trop Med Hyg 1994; 51:837-46.
4. Rausch RL, Wilson JF, Schantz PM, McMahon BJ. Spontaneous death of Echinococcus multilocularis: cases diagnosed serologically (by Em2 ELISA) and clinical significance. Am J Trop Med Hyg 1987; 36:576-85.
5. Gottstein B, Felleisen R. Protective immune mechanisms against the metacestode of Echinococcus multilocularis. Parasit Today 1995; 11:320-6.
6. Vuitton DA. The ambiguous role of immunity in echinococcosis. Protection of the host or of the parasite? Acta Trop 2003; 85:119-32.
7. Sturm D, Menzel J, Gottstein B, Kern P. Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis. Infect Immun 1995; 63:1688-97.
8. Godot V, Harraga S, Beurton I et al. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. I. Comparison of patients with progressive and abortive lesions. Clin Exp Immunol 2000; 121:484-90.
9. Shi DZ, Li FR, Bartholomot B, Vuitton DA, Craig PS. Serum sIL-2R, TNFα and IFN-γ in alveolar echinococcosis. World J Gastroenterol 2004; 10:3674-6.
10. Dreweck CM, Soboslay PT, Schulz-Key H, Gottstein B, Kern P. Cytokine and chemokine secretion by human peripheral blood cells in response to viable Echinococcus multilocularis metacestode vesicles. Parasite Immunol 1999; 21:433-8.
11. Kilwinski J, Jenne L, Jellen-Ritter A, Radloff P, Flick W, Kern P. T lymphocyte cytokine profile at a single cell level in alveolar echinococcosis. Cytokine 1998; 11:373-81.
12. Eger A, Kirch A, Manfras B, Kern P, Schulz-Key H, Soboslay PT. Pro-inflammatory (IL-1α, IL-18) cytokines and IL-8 chemokine release by PBMC in response to Echinococcus multilocularis metacestode vesicles. Parasite Immunol 2003; 25:103-5.
13. Vuitton DA. Echinococcosis and allergy. Clin Rev Allergy Immunol 2004; 26:93-104.
14. Hemphill A, Stettler M, Walker M, Siles-Lucas M, Fink R, Gottstein B. In vitro culture of Echinococcus multilocularis and Echinococcus vogeli metacestodes: studies on the host-parasite interface. Acta Trop 2003; 85:145-55.
15. Walker M, Baz A, Dematteis S et al. Isolation and characterization of a secretory component of Echinococcus multilocularis metacestodes potentially involved in modulating the host-parasite interface. Infect Immun 2004; 72:527-36.
16. Emery I, Liance M, Deriaud E. Vuitton DA, Houin R, Leclerc C. Characterization of T-cell immune responses of Echmococcus multilocularis- infected C57BL/6J mice. Parasite Immunol 1996; 18:463-72.
17. Bresson-Hadni S, Vuitton DA, Lenys D, Liance M, Racadot E, Miguet JP. Cellular immune response in Echinococcus multilocularis infection in humans. I. Lymphocyte reactivity to Echinococcus antigens in patients with alveolar echinococcosis. Clin Exp Immunol 1989; 78:61-6.
18. Vuitton DA, Bresson-Hadni S, Laroche L et al. Cellular immune response in Echinococcus multilocularis infection in humans. II. Natural killer cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients with alveolar echinococcosis. Clin Exp Immunol 1989; 78:67-74.
19. Dixon JB. Echinococcosis. Comp Immunol Microbiol Infect Dis 1997; 20:87-94.
20. h1 CD4 memory T cell generation in chronic-persisting liver infection with Echinococcus multilocularis. Int Immunol 2004; 16:43-50.
21. Bresson-Hadni S, Petitjean O, Monnot-Jacquard B et al. Cellular localisations of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha mRNA in a parasitic granulomatous disease of the liver, alveolar echinococcosis. Eur Cytokine Netw 1994; 5:461-8.
22. Smythies LE, Sellers M, Clements RH et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 2005; 115:66-75.
23. Kunkel EJ, Butcher EC. Chemokines and the tissue-specific migration of lymphocytes. Immunity 2002; 16:1-4.
24. Fujii H, Shimada Y, Hasegawa M, Takehara K, Sato S. Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis. J Dermatol Sci 2004; 35:43-51.
25. Nomura I, Gao B, Boguniewicz M, Darst MA, Travers JB, Leung DY. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 2003; 112:1195-202.
26. Katoh S, Fukushima K, Matsumoto N et al. Accumulation of CCR4-expressing CD4+ T cells and high concentration of its ligands (TARC and MDC) in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. Allergy 2004; 58:518-23.
27. Fendt J, Hamm DM, Banla M et al. Chemokines in onchocerciasis patients after a single dose of ivermectin. Clin Exp Immun 2005; 142:318-26.
28. Jakubzick C, Wen H, Matsukawa A, Keller M, Kunkel SL, Hogaboam CM. Role of CCR4 ligands, CCL17 and CCL22, during Schistosoma mansoni egg-induced pulmonary granuloma formation in mice. Am J Pathol 2004; 165:1211-21.
29. Emery I, Leclerc C, Sengphommachanh K, Vuitton DA, Liance M. In vivo treatment with recombinant IL-12 protects C57BL/6J mice against secondary alveolar echinococcosis. Parasite Immunol 1998; 20:81-91.
30. Amiot F, Vuong P, Defontaines M, Pater C, Dautry F, Liance M. Secondary alveolar echinococcosis in lymphotoxin-alpha and tumor necrosis factor-alpha deficient mice, exacerbation of Echinococcus multilocularis larval growth is associated with cellular changes in the periparasitic granuloma. Parasite Immunol 1999; 21:475-83.
31. McInnes IB, Leung BP, Harnett M, Gracie JA, Liew FY, Harnett W. A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62. J Immunol 2003; 171:2127-33.
32. Kane CM, Cervi L, Sun J et al. Helminth antigens modulate TLR-initiated dendritic cell activation. J Immunol 2004; 173:7454-61.
33. Schierack P, Lucius R, Sonnenburg B, Schilling K, Hartmann S. Parasite-specific immunomodulatory functions of filarial cystatin. Infect Immun 2003; 71:2422-9.
34. Harnett W, Harnett MM, Leung BP, Gracie JA, McInnes IB. The anti-inflammatory potential of the filarial nematode secreted product, ES-62. Curr Top Med Chem 2004; 4:553-9.
35. Mangan NE, Fallon RE, Smith P, Van Rooijen N, McKenzie AN, Fallon PG. Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. J Immunol 2004; 173:6346-56.
36. Pinto LA, Pitrez PM, Fontoura GR et al. Infection of BALB/c mice with Angiostrongylus costancensis decreases pulmonary inflammatory response to ovalbumin. Parasite Immunol 2004; 26:151-5.
37. Sewell D, Qing Z, Reinke E et al. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol 2003; 15:59-69.
38. Summers RW, Elliott DE, Urban JF Jr, Thompson RA, Weinstock JV. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 2005; 128:1117-9.
39. Zaccone P, Fehervari Z, Jones FM et al. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 2003; 33:1439-49.